Antoni TrillaResearch Professor, Decano de la Facultad de Medicina y Ciencias de la Salud, UB Infecciones Víricas y Bacterianas, Virus emergentes
Antoni Trilla is a MD and PhD by the University of Barcelona, and has a Master in Hospital and Health Services Management (UB) and in Health Economics and Health Management (UPF-UB).
He is board certified in Internal Medicine and in Preventive Medicine and Public Health.
He is currently Research Professor at ISGlobal and Dean of the Faculty of Medicine and Health Sciences (University of Barcelona)
Trilla is also Head of the Preventive Medicine and Epidemiology Unit and is Faculty staff at the Hospital Clinic of Barcelona-UB, where he teaches Preventive Medicine and Public Health.
As expert in infectious diseases, he coordinates the High Level Isolation Unit (UAAN) (National Reference Center for Highly Infectious Diseases), he chairs the Scientific Advisory Committee for Emerging Infections of Catalonia, and is scientific advisor for the European Center for Disease Control (ECDC)
He is a member of the Institut d’Estudis Catalans (IEC), of the Reial Acadèmia de Medicina de Catalunya (RAMC) and of the Governing Board of the Barcelona College of Physicians (CoMB) .
Previous positions include director of Quality and Clinical Safety at the Hospital Clínic, and president of the Catalan Agency for Health Quality and Assessment (AQuAS).
He has authored more than 250 original papers published in peer-reviewed journals and has been principal or associate investigator in 25 research projects
Lines of research
- Vaccines and vaccination
- Emerging infectious diseases - prevention and control
- Outbreaks and epidemics management and crisis communication
1.- Brouqui P, Puro V, Fusco FM, et al. Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease. Lancet Infect Dis. 2009 May;9(5):301-11. doi: 10.1016/S1473-3099(09)70070-2.
2.- Schilling S, Fusco FM, De Iaco G, et al. Isolation facilities for highly infectious diseases in Europe--a cross-sectional analysis in 16 countries. PLoS One. 2014 Oct 28;9(10):e100401. doi: 10.1371/journal.pone.0100401
3.- Rubio E, Martínez MJ, Gonzalo V, et al. Definitive diagnosis in suspected Middle East Respiratory Syndrome Coronavirus cases. J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tax084.
4.- Llupià A, Puig J, Mena G, Bayas JM, Trilla A. The social network around influenza vaccination in health care workers: a cross-sectional study. Implement Sci. 2016 Nov 24;11(1):152 .doi: 10.1186/s13012-016-0522-3
5.- Soto M, Sampietro-Colom L, Vilella A, et al. Economic Impact of a New Rapid PCR Assay for Detecting Influenza Virus in an Emergency Department and Hospitalized Patients. PLoS One. 2016 Jan 20;11(1):e0146620. doi: 10.1371/journal.pone.0146620
ORCID ID: 0000-0002-6869-0242